HOME Top Market Reports Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021

Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: MD 3211

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The hemodynamic monitoring systems market is reach USD 1,143.7 Million by 2021, growing at a CAGR of 4.3% during the forecast period of 2016 to 2021. The growth of the overall market can be technological advancements, growth in the number of people suffering from hypertension, growing diabetes population, and rapid growth in the aging population are the significant growth drivers for this market. Moreover, growth in aging population and the number of people suffering from diseases in populous countries such as India and China are the factors that are expected to offer significant growth opportunities for Hemodynamic Monitoring Systems. However, risks associated with invasive hemodynamic monitoring such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is the challenge to invasive market.

This report segments the hemodynamic monitoring systems market based on product, types, and end user. The product segments described in the report are systems and disposables. The disposables segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the as increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theatres (OTs) for monitoring of patients with critical illness and hemodynamic instability. Additionally, this segment is projected to grow at the highest CAGR. The hospitals are expected to account for the largest share of the global market, end user, in 2016. The large share of this segment is mainly attributed to rising aging population and the increasing prevalence of diseases such as cardiovascular and diabetes.

North America is estimated to account for the largest share of the global hemodynamic monitoring systems market. Technological advancements and initiatives adopted by industry players to boost hemodynamic monitoring system Market in U.S. Additionally rising usage of heart patient monitoring systems in Canada, high diabetes prevalence to boost the market for hemodynamic monitoring systems in North America. Asia-Pacific is expected to account for the second-largest share of the market

In the coming years, The hemodynamic monitoring systems market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India and the Rest of Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as rising incidence of aging population in China and high diabetes prevalence in India, Vietnam, Singapore, Malaysia and China are driving the growth of the market in this region.

In 2015, the key players of the hemodynamic monitoring systems were Edwards Lifesciences Corporation (US.), Pulsion Medical Systems SE (Germany) and LiDCO Group plc (U.K.). These companies together contributed ~65%  of the Global Market in 2015. The other players of the market are Cheetah Medical Inc. (Israel), Deltex Medical Group Plc. (U.K.), Hemo Sapiens , In. (U.S.), ICU Medical, Inc. (U.S.), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany) and Tensys Medical, Inc. (U.S.).

Target Audience:

  • Hemodynamic monitoring systems  equipment manufacturers
  • Original equipment manufacturers
  • Suppliers And distributors of hemodynamic monitoring systems  equipment
  • Teaching hospitals and academic medical centers (AMCs)
  • Research and consulting firms
  • Venture capitalists
  • Community centers

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes hemodynamic monitoring systems market into the following segments:

Hemodynamic Monitoring Systems Market, by Product

  • Systems
  • Disposables

Hemodynamic Monitoring Systems Market, by Type

  • Invasive Monitoring Systems
  • Minimally Invasive Monitoring Systems
  • Non- Invasive Monitoring Systems

Hemodynamic Monitoring Systems Market, by End-User

  • Hospitals
  • Cath Labs
  • Home and Ambulatory Sites

Hemodynamic Monitoring Systems Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

  • With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies in the market
  • Detailed analysis and profiling of additional market players (up to 3)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                     2.2.2.1 Key Data From Primary Sources
                     2.2.2.2 Key Insights From Primary Sources
                     2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 29)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Overview of the Market, (2016-2021)
    4.2 Market, By Product
    4.3 Market, By Type
    4.4 Market, By End User
    4.5 Geographic Analysis of the Market

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                     5.3.1.1 Technological Advancements in Hemodynamic Monitoring Systems
                                       5.3.1.1.1 Noninvasive Hemodynamic Monitoring Systems
                                       5.3.1.1.2 Micro-Electro-Mechanical Systems (Mems) Technology
                     5.3.1.2 Increasing Initiatives By Industry Players
                     5.3.1.3 Rising Prevalence of Cardiovascular Diseases and Diabetes
                     5.3.1.4 Rapid Growth in Aging Population
           5.3.2 Challenge
                     5.3.2.1 Risks Associated With Invasive Hemodynamic Monitoring
           5.3.3 Opportunity
                     5.3.3.1 India and China Provide Significant Market Growth Opportunities

6 Hemodynamic Monitoring Systems Market, By Product (Page No. - 45)
    6.1 Introduction
    6.2 Systems (Monitors)
    6.3 Disposables

7 Hemodynamic Monitoring Systems Market, By Type (Page No. - 52)
    7.1 Introduction
    7.2 Invasive Hemodynamic Monitoring Systems
    7.3 Minimally Invasive Hemodynamic Monitoring Systems
    7.4 Noninvasive Hemodynamic Monitoring Systems

8 Hemodynamic Monitoring Systems Market, By End User (Page No. - 63)
    8.1 Introduction
    8.2 Hospitals
    8.3 Cath Labs
    8.4 Home and Ambulatory Care

9 Global Hemodynamic Monitoring Systems Market, By Region (Page No. - 71)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
                     9.2.1.1 Technological Advancements in Hemodynamic Monitoring Systems in the U.S.
                     9.2.1.2 Initiatives Adopted By Industry Players to Boost Market in U.S.
                     9.2.1.3 Favorable Reimbursement Environment Likely to Drive the Hemodynamic Monitors Market
                     9.2.1.4 Increasing Prevalence of Hypertension
                     9.2.1.5 Growing Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
           9.2.2 Canada
                     9.2.2.1 Rising Usage of Heart Monitoring Systems in Canada
                     9.2.2.2 High Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
    9.3 Europe
           9.3.1 Europe-5
                     9.3.1.1 Rising Prevalence of Diabetes and Cardiovascular Diseases in the U. K.
                     9.3.1.2 Initiatives Adopted By Nhs England for the Implementation of Hemodynamic Monitoring Systems
                     9.3.1.3 Conferences on Hemodynamic Monitoring Systems in European Countries
                     9.3.1.4 Active Involvement of Industry Players to Augment the Demand for Hemodynamic Monitoring System in Europe-5
                     9.3.1.5 S3 Guidelines for Intensive Care in Cardiac Surgeries
                     9.3.1.6 Odm as A Standard of Care in France
           9.3.2 RoE
                     9.3.2.1 Hemodynamic Monitoring Systems Gaining Momentum in the Netherlands and Sweden
                     9.3.2.2 High Diabetes Prevalence in European Countries
    9.4 Asia-Pacific
           9.4.1 Japan
                     9.4.1.1 Active Involvement of LiDCO Group PLC in Japan
           9.4.2 China
                     9.4.2.1 Company Initiatives to Enhance Product Availability in China
                     9.4.2.2 Rising Incidence of Diabetes and Rapidly Aging Population
           9.4.3 India
                     9.4.3.1 High Diabetes Prevalence to Accelerate the Market Growth in India
           9.4.4 RoAPAC
                     9.4.4.1 Adoption of Hemodynamic Monitoring Systems in Vietnam, Singapore, & Malaysia
                     9.4.4.2 Tensys Medical’s Marketing Strategy to Bolster the Market for Noninvasive Hemodynamic Monitoring in China and Taiwan
                     9.4.4.3 High Diabetes Prevalence and Rising Incidence of CVD in Pacific Countries
    9.5 RoW
           9.5.1 High Diabetes Prevalence in Brazil
           9.5.2 LiDCO’s Marketing Strategy to Bolster the Market for Hemodynamic Monitoring in Africa
           9.5.3 High Diabetes Prevalence Driving the Adoption of Hemodynamic Monitoring in the Middle East & Africa

10 Competitive Landscape (Page No. - 103)
     10.1 Overview
     10.2 Competitive Situation and Trends
     10.3 Market Share Analysis
               10.3.1 Introduction
               10.3.2 Edwards Lifesciences Corporation
               10.3.3 Pulsion Medical Systems Se
               10.3.4 LiDCO Group PLC.
     10.4 Competitive Scenario
               10.4.1 Agreements, Collaborations, and Joint Ventures
               10.4.2 Product Launches
               10.4.3 Mergers and Acquisitions
               10.4.4 Other Strategies

11 Company Profiles (Page No. - 113)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Edwards Lifesciences Corporation
     11.2 Pulsion Medical Systems Se (Part of the Maquet Getinge Group)
     11.3 LiDCO Group PLC
     11.4 Cheetah Medical, Inc.
     11.5 Deltex Medical Group PLC
     11.6 Hemo Sapiens, Inc.
     11.7 ICU Medical, Inc.
     11.8 Osypka Medical GmbH
     11.9 Schwarzer Cardiotek GmbH
     11.10 Tensys Medical, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 129)
     12.1 Discussion Guide
     12.2 Company Developments (2013–2016)
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (89 Tables)

Table 1 Few of the Developments in This Regard are Listed Below:
Table 2 Top 5 Countries With the Highest Number of Diabetics (Aged 20–79 Years), 2015 vs 2040
Table 3 Population Aged 60 Years and Over, By Region (Million Individuals)
Table 4 Global Market Size, By Product, 2014-2021 (USD Million)
Table 5 Global Market Size, By Region, 2014–2021 (USD Million)
Table 6 Types of Hemodynamic Monitoring Systems
Table 7 Hemodynamic Monitors Market Size, By Region, 2014–2021 (USD Million)
Table 8 North America: Hemodynamic Monitors Market Size, By Country, 2014–2021 (USD Million)
Table 9 Europe: Hemodynamic Monitors Market Size, By Region, 2014–2021 (USD Million)
Table 10 Asia-Pacific: Hemodynamic Monitors Market Size, By Country/Region, 2014–2021 (USD Million)
Table 11 Types of Disposables Used in Hemodynamic Monitoring
Table 12 Disposables Market Size, By Region, 2014–2021 (USD Million)
Table 13 North America: Hemodynamic Monitoring Disposables Market Size, By Country, 2014–2021 (USD Million)
Table 14 Europe: Hemodynamic Monitoring Disposables Market Size, By Region, 2014–2021 (USD Million)
Table 15 Asia-Pacific: Hemodynamic Monitoring Disposables Market Size, By Country/Region, 2014–2021 (USD Million)
Table 16 Global Market Size, By Type, 2014–2021 (USD Million)
Table 17 Market Size, By Type, 2014–2021 (Units)
Table 18 Invasive Monitoring Systems Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Invasive Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Invasive Market Size, By Region, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Invasive Market Size, By Country/Region, 2014–2021 (USD Million)
Table 22 Invasive Market Size, By Region, 2012–2019 (Units)
Table 23 Minimally Invasive Monitoring Systems Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Minimally Invasive Hemodynamic Monitoring Systems Market Size, By Country, 2014–2021 (USD Million)
Table 25 Europe: Minimally Invasive Hemodynamic Monitoring Systems Market Size, By Region, 2014–2021 (USD Million)
Table 26 Asia-Pacific: Minimally Invasive Hemodynamic Monitoring Systems Market Size, By Country/By Region, 2014–2021 (USD Million)
Table 27 Minimally Invasive Hemodynamic Monitoring Systems Market Size, By Region, 2012–2019 (Units)
Table 28 Non Invasive Monitoring Systems Market Size, By Region, 2014–2021 (USD Thousand)
Table 29 North America: Noninvasive Hemodynamic Monitoring Systems Market Size, By Country, 2014–2021 (USD Thousand)
Table 30 Europe: Noninvasive Hemodynamic Monitoring Systems Market Size, By Region, 2014–2021 (USD Thousand)
Table 31 Asia-Pacific: Noninvasive Hemodynamic Monitoring Systems Market Size, By Country/Region, 2014–2021 (USD Thousand)
Table 32 Non Invasive Hemodynamic Monitoring Systems Market Size, By Region, 2012–2019 (Units)
Table 33 Global Market Size, By End User, 2014–2021 (USD Million)
Table 34 Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 35 North America: Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 36 Europe: Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 37 Asia-Pacific: Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 38 Market Size for Cath Labs, By Region, 2014–2021 (USD Million)
Table 39 North America: Market Size for Cath Labs, By Country, 2014–2021 (USD Million)
Table 40 Europe: Market Size for Cath Labs, By Region, 2014–2021 (USD Million)
Table 41 Asia-Pacific: Market Size for Cath Labs, By Country, 2014–2021 (USD Million)
Table 42 Market Size for Home and Ambulatory Care, By Region, 2014–2021 (USD Thousand)
Table 43 North America: Market Size for Home and Ambulatory Care, By Country, 2014–2021 (USD Thousand)
Table 44 Europe: Market Size for Home and Ambulatory Care, By Region, 2014–2021 (USD Thousand)
Table 45 Asia-Pacific: Market Size for Home and Ambulatory Care, By Country, 2014–2021 (USD Thousand)
Table 46 Market Size, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 48 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 49 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 50 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 51 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 52 U.S.: Market Size, By Type, 2014–2021 (USD Million)
Table 53 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 54 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 55 Canada: Market Size, By Type, 2014–2021 (USD Thousand)
Table 56 Canada: Market Size, By End User, 2014–2021 (USD Thousand)
Table 57 Europe: Market Size, By Region, 2014–2021 (USD Million)
Table 58 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 59 Europe: Market Size, By Type, 2014–2021 (USD Thousand)
Table 60 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Europe-5: Market Size, By Product, 2014–2021 (USD Million)
Table 62 Europe-5: Market Size, By Type, 2014–2021 (USD Thousand)
Table 63 Europe-5: Market Size, By End User, 2014–2021 (USD Million)
Table 64 RoE: Market Size, By Product, 2014–2021 (USD Million)
Table 65 RoE: Market Size, By Type, 2014–2021 (USD Thousand)
Table 66 RoE: Market Size, By End User, 2014–2021 (USD Thousand)
Table 67 Asia-Pacific: Market Size, By Country/Region, 2014–2021 (USD Million)
Table 68 Asia-Pacific: Market Size, By Product, 2014–2021 (USD Million)
Table 69 Asia-Pacific: Market Size, By Type, 2014–2021 (USD Million)
Table 70 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 71 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 72 Japan: Market Size, By Type, 2014–2021 (USD Million)
Table 73 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 74 China: Market Size, By Product, 2014–2021 (USD Million)
Table 75 China: Market Size, By Type, 2014–2021 (USD Thousand)
Table 76 China: Market Size, By End User, 2014–2021 (USD Thousand)
Table 77 India: Market Size, By Product, 2014–2021 (USD Million)
Table 78 India: Market Size, By Type, 2014–2021 (USD Thousand)
Table 79 India: Market Size, By End User, 2014–2021 (USD Thousand)
Table 80 RoAPAC: Market Size, By Product, 2014–2021 (USD Million)
Table 81 RoAPAC: Market Size, By Type, 2014–2021 (USD Thousand)
Table 82 RoAPAC: Market Size, By End User, 2014–2021 (USD Thousand)
Table 83 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 84 RoW: Market Size, By Type, 2014–2021 (USD Thousand)
Table 85 RoW: Market Size, By End User, 2014–2021 (USD Thousand)
Table 86 Agreements, Collaborations, and Joint Ventures, (2013–2016)
Table 87 Product Launches, (2013–2016)
Table 88 Mergers and Acquisitions, (2013–2016)
Table 89 Other Developments, 2013–2016
 
 
List of Figures (41 Figures)
 
Figure 1 Global Market Segmentation
Figure 2 Global Market: Research Methodology
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Global Market Analysis, By Product (2016)
Figure 9 Global Market Analysis, By Type, 2016 vs 2021
Figure 10 Global Market Analysis, By End User, 2016 vs 2021
Figure 11 Asia-Pacific Market to Witness Highest Growth During the Forecast Period
Figure 12 Attractive Opportunities in the Market
Figure 13 Disposables Segment to Grow at the Highest Rate (2016-2021)
Figure 14 Minimally Invasive Hemodynamic Monitoring Systems Segment to Witness Highest Growth During the Forecast Period
Figure 15 Hospitals to Command the Largest Share of the Market in 2021
Figure 16 North America to Dominate the Market
Figure 17 Global Hemodynamic Monitoring System Market Segmentation
Figure 18 Drivers, Challenge, and Opportunities
Figure 19 Percentage Change in Population Aged 60 Years and Over, By Region (2000–2030)
Figure 20 Market, By Product
Figure 21 Global Market, By Type, 2016 vs 2021
Figure 22 Market Segmentation, By End User
Figure 23 Market, By Region, 2016 vs 2021
Figure 24 North America: Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Europe: Number of Diabetics, By Country, 2015 (Million Cases)
Figure 27 Asia-Pacific: Market Snapshot
Figure 28 RoW Market Snapshot
Figure 29 Major Growth Strategies Adopted, By Company
Figure 30 Market Share Analysis, By Key Player (2015)
Figure 31 Agreement, Collaboration & Joint Ventures: the Key Growth Strategies Adopted By Market Players
Figure 32 Agreements, Collaborations, and Joint Ventures, By Company (2013–2016)
Figure 33 Product Launches (2013–2016)
Figure 34 Merger and Acquisitions, By Company (2013–2016)
Figure 35 Other Strategies, By Company (2013–2016)
Figure 36 Geographic Presence of Key Players
Figure 37 Edwards Lifesciences Corporation: Company Snapshot
Figure 38 Pulsion Medical Systems Se: Company Snapshot
Figure 39 LiDCO Group PLC: Company Snapshot
Figure 40 Deltex Medical Group PLC: Company Snapshot
Figure 41 ICU Medical Inc.: Company Snapshot

The global hemodynamic monitoring systems market is expected to reach USD 1,143.7 Million by 2021 from USD 925.2 Million in 2016, growing at a CAGR of 4.3% from 2016 to 2021.

The global hemodynamic monitoring systems market has been segmented on the basis of product, type, end user, and region. By product, the market is segmented into systems and disposables. The disposables segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theaters (OTs) for the monitoring of patients with critical illnesses and hemodynamic instability.

On the basis of type, the global hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive hemodynamic monitoring systems. The minimally invasive monitoring systems segment is estimated to grow at the highest CAGR in 2016, due to factors such as increased utilization of minimally invasive hemodynamic monitoring systems in the field of anesthesia.

On the basis of end user, the global hemodynamic monitoring systems market is broadly segmented into hospitals, cath labs, and home and ambulatory sites. The hospitals segment is estimated to account for the largest share of the global market in 2016. This segment is also projected to grow at the highest CAGR in the forecast period.Additionally, this segment is projected to grow at the highest CAGR.

On the basis of region, the hemodynamic monitoring systems market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is estimated to account for the largest share of the market, followed by Asia-Pacific, Europe, and the RoW. The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering hemodynamic monitoring systems. The high growth in this segment can be attributed to the growing aging population in India and China and the increasing demand for critical care units (CCUs).

Hemodynamic Monitoring Systems Market

Source: International Hemodynamic Society (IHS), Association for the Advancement of Medical Instrumentation (AAMI), International Diabetes Federation (IDF), National Health Service (NHS), New York Heart Association (NYHA), National Institute on Aging (NIA),  American Association of Critical-Care Nurses (AACN), Intensive Care National Audit & Research Centre (ICNARC), European Society of Intensive Care Medicine, American College of Cardiology (ACC), Expert Interviews, and MarketsandMarkets Analysis

In 2015, the hemodynamic monitoring systems market was dominated by Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group plc. (U.K.). The other players in the market are Cheetah Medical Inc. (Israel), Deltex Medical Group plc. (U.K.), Hemo Sapiens, Inc. (U.S.), ICU Medical, Inc. (U.S.), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany), and Tensys Medical, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo